NCT02675946 CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) Status UNKNOWN Phase PHASE1
NCT02674061 Efficacy and Safety Study of Pembrolizumab (MK-3475) in Participants With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100) Status COMPLETED Phase PHASE2
NCT02673333 Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02666352 A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029) Status COMPLETED Phase PHASE1
NCT02665650 Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT02663258 A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM) Status WITHDRAWN Phase PHASE2
NCT02661126 Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030) Status COMPLETED Phase PHASE1
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA
NCT02658019 Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02657889 Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02657148 Immediate Postpartum Nexplanon Placement in Opioid Dependent Women Status COMPLETED Phase N/A
NCT02655471 Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Status COMPLETED Phase EARLY_PHASE1
NCT02653118 Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02652260 Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Status COMPLETED Phase PHASE2
NCT02648503 Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy Status UNKNOWN Phase PHASE4
NCT02648477 Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02648282 Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02645396 A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China Status COMPLETED Phase N/A
NCT02644369 Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02642809 Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers Status COMPLETED Phase PHASE1